CLTI challenges & solutions: Dr. Prakash Krishnan on resorbable scaffolds

In this PVI 2025 exclusive interview, Dr. Prakash Krishnan shares his insights on bioresorbable scaffolds and their potential role in treating complex CLTI (Chronic Limb-Threatening Ischemia) patients.

Following the LIFE-BTK trial, drug-eluting bioresorbable scaffolds are now approved in the U.S., offering temporary support for dissections or recoil without limiting future treatment options.

Key questions remain: How do they perform in long lesions or above-the-ankle interventions? What is the best vessel preparation strategy? While the potential is exciting, Dr. Krishnan stresses that more evidence is needed before widespread adoption.

Watch the full interview to see how these scaffolds could change complex CLTI management.